Clinical Trial Update: UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating infusion of umbilical cord-derived mesenchymal stem cells (UC-MSC) for HBV-related acute-on-chronic liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure
• On Chronic Liver Failure

Drugs mentioned

• UC-MSC infusion (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Failure | Phase 2 | Status: UNKNOWN